Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 October 2019 | Story Xolisa Mnukwa | Photo Charl Devenish
Gradstar UFS
The 2019 GradStar programme is all about producing well-rounded students and providing them with opportunities in the world of work, explained Head of UFS Career Services, Belinda Janeke.

Congratulations to the Kovsies top-11 students who made it into the GradStar top-100 programme for 2019!

Each year, 100 South African students are selected through a rigorous four-phase judging process to become part of the GradStar programme. The programme is designed to offer opportunities for employment to previously unrecognised students.

What makes the top 11? 

According to the UFS Head of Career Services, Belinda Janeke, the GradStar programme is all about producing a well-rounded student. Approximately 6 000 applications were received from Kovsies, of which 500 were selected based on a personality test. Another test was given to the 500 students who passed the personality test, after which interviews were conducted to determine the top 100 from the UFS.  

The students who were selected to represent the UFS exhibited the most potential as future leaders in their respective fields. Apart from academic achievement, contestants were evaluated according to their individual soft skills such as motivation, discipline, altruism, and attitude. This combination promised to deliver top candidates for future employers. 

2019 GradStar programme experiences

Throughout the competition, Kovsie contestants were exposed to new people and opportunities to network with various companies in their preferred career fields, where they had the opportunity to share their CVs with potential employers. Contestants were also afforded the opportunity to develop critical problem-solving skills in the world of work. The GradStar top-100 students also have a WhatsApp group where jobs are advertised.

The programme was valuable for the Kovsies; not only did it prepare them for employment, but also provided them with an opportunity for learning and recognising their own strengths and weaknesses as individuals in the working world. 

Congratulations to the Kovsies who made it into the GradStar top 100: 

Mariné du Toit: Bachelor of Social Work
Nyiko Maluleka: Bachelor of Arts, Corporate and Marketing Communication
Bianca Malan: Bachelor of Accounting, Financial Accounting
Boitumelo Mancoe: Master of Business Administration
Kabelo Mashego: Bachelor of Medicine and Bachelor of Surgery (MB ChB)
Kananelo Moletsane: Bachelor of Agriculture
Mudzunga Mukwevho: Bachelor of Accounting, Financial Accounting
Neo Roberts: Bachelor of Science, Information Technology 
Refilwe Maimane: Bachelor of Commerce, Accounting 
Themba Makhoba: Bachelor of Public Administration
Mpolokeng Mmutle: Bachelor of Commerce, Accounting

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept